Cladribine (intravenous)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cladribine (intravenous), covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine [Phase 1]